What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.53%Below 5Y avg (0.71%)
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
8.4%Sustainable
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.41BCNY
811.39M · vs all stocks (USD)
Updated Nov 18, 2026
Trailing P/E
15.79x
vs Conglomerates peers
Updated Nov 18, 2026
Revenue (TTM)
4.54BCNY
680.34M · vs all stocks (USD)
Updated Nov 18, 2026
Profit Margin
7.59%
vs Conglomerates peers
Updated Nov 18, 2026
Beta
0.8080x
vs all stocks
Updated Nov 18, 2026
52-Week Change
1.27%
vs all stocks
Updated Nov 18, 2026
Forward Annual Dividend Yield
0.53%
vs all stocks
Updated Nov 18, 2026
Market Capitalization
5.41BCNY
811.39M · vs all stocks (USD)
Updated Nov 18, 2026
Enterprise Value
5.00BCNY
750.69M · vs all stocks (USD)
Updated Nov 18, 2026
Trailing P/E
15.79x
vs Conglomerates peers
Updated Nov 18, 2026
Price to Sales (TTM)
1.20x
vs Conglomerates peers
Updated Nov 18, 2026
Price to Book (MRQ)
1.70x
vs Conglomerates peers
Updated Nov 18, 2026
Enterprise to Revenue
1.10x
vs Conglomerates peers
Updated Nov 18, 2026
Enterprise to EBITDA
8.22x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.02×.Updated Nov 18, 2026
Gross Margin
24.02%
vs Conglomerates peers
Updated Nov 18, 2026
Profit Margin
7.59%
vs Conglomerates peers
Updated Nov 18, 2026
Operating Margin
11.26%
vs Conglomerates peers
Updated Nov 18, 2026
Return on Assets (TTM)
4.85%
vs Conglomerates peers
Updated Nov 18, 2026
Return on Equity (TTM)
11.29%
vs Conglomerates peers
Updated Nov 18, 2026
Revenue (TTM)
4.54BCNY
680.34M · vs all stocks (USD)
Updated Nov 18, 2026
Revenue per Share (TTM)
9.36CNYUpdated Nov 18, 2026
Quarterly Revenue Growth
13.00%
vs Conglomerates peers
Updated Nov 18, 2026
Gross Profit (TTM)
1.17BCNY
175.03M · vs all stocks (USD)
Updated Nov 18, 2026
EBITDA (TTM)
555.00MCNY
83.25M · vs all stocks (USD)
Updated Nov 18, 2026
Net Income (TTM)
344.46MCNY
51.67M · vs all stocks (USD)
Updated Nov 18, 2026
Quarterly Earnings Growth (YoY)
54.10%
vs Conglomerates peers
Updated Nov 18, 2026
Operating Cash Flow (TTM)
715.77MCNY
107.36M · vs all stocks (USD)
Updated Nov 18, 2026
Levered Free Cash Flow (TTM)
407.75MCNY
61.16M · vs all stocks (USD)
Updated Nov 18, 2026
Forward Annual Dividend Rate
0.0600CNYUpdated Nov 18, 2026
Forward Annual Dividend Yield
0.53%
vs all stocks
Updated Nov 18, 2026
Trailing Annual Dividend Rate
0.0600CNYUpdated Nov 18, 2026
Trailing Annual Dividend Yield
0.53%
vs all stocks
Updated Nov 18, 2026
5-Year Average Dividend Yield
0.71%
vs all stocks
Updated Nov 18, 2026
Payout Ratio
8.44%
vs Conglomerates peers
Updated Nov 18, 2026
Minority Interest (Equity)
1.12BCNYFY2025 · Dec 31, 2025
Revenue
4.22BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.10BCNYFY2025 · Dec 31, 2025
Gross Profit
1.12BCNYFY2025 · Dec 31, 2025
Operating Income
495.04MCNY
74.25M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
493.79MCNYFY2025 · Dec 31, 2025
Income Tax Expense
63.18MCNYFY2025 · Dec 31, 2025
Net Income
430.61MCNYFY2025 · Dec 31, 2025
EBIT
506.24MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
656.02MCNYFY2025 · Dec 31, 2025
Research & Development
237.11MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
88.82MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
45.43MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
24.18MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
12.45MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.6105CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.6096CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
483.15MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
483.15MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
430.61MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-135.65MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
438.93MCNYFY2025 · Dec 31, 2025
Free Cash Flow
256.39MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.38BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
430.61MCNYFY2025 · Dec 31, 2025
Stock-based Compensation
1.47MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
12.02MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-145.43MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
140.26MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-182.53MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-4.60MCNYFY2025 · Dec 31, 2025
Sale of Investments
34.54MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-40.00MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-192.59MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
284.55MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-381.55MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-48.05MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-23.51MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-168.56MCNYFY2025 · Dec 31, 2025
Shares Outstanding
484.73MSharesUpdated Nov 18, 2026
Float Shares
303.97MSharesUpdated Nov 18, 2026
% Held by Insiders
44.81%
vs all stocks
Updated Nov 18, 2026
% Held by Institutions
1.37%
vs all stocks
Updated Nov 18, 2026
Total Cash (MRQ)
1.76BCNY
263.62M · vs all stocks (USD)
Updated Nov 18, 2026
Total Cash per Share (MRQ)
3.63CNYUpdated Nov 18, 2026
Total Debt (MRQ)
179.63MCNY
26.94M · vs all stocks (USD)
Updated Nov 18, 2026
Total Debt to Equity (MRQ)
0.0414x
vs Conglomerates peers
Updated Nov 18, 2026
Current Ratio (MRQ)
1.90x
vs Conglomerates peers
Updated Nov 18, 2026
Book Value per Share (MRQ)
6.59CNYUpdated Nov 18, 2026
Total Assets
6.42BCNY
963.66M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
4.26BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.40BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.16BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
140.64MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
2.26BCNYFY2025 · Dec 31, 2025
Cash
860.35MCNYFY2025 · Dec 31, 2025
Cash Equivalents
636.39MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.50BCNYFY2025 · Dec 31, 2025
Accounts Receivable
954.37MCNYFY2025 · Dec 31, 2025
Inventory
1.25BCNYFY2025 · Dec 31, 2025
Accounts Payable
1.33BCNYFY2025 · Dec 31, 2025
Short-term Debt
268.09MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
26.81MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.49MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
484.73MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.65BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
4.03BCNY
603.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
6.47MCNYFY2025 · Dec 31, 2025
52-Week Low
10.51CNYUpdated Nov 18, 2026
52-Week High
21.98CNYUpdated Nov 18, 2026
52-Week Change
1.27%
vs all stocks
Updated Nov 18, 2026
Beta
0.8080x
vs all stocks
Updated Nov 18, 2026
50-Day MA
11.66CNYUpdated Nov 18, 2026
200-Day MA
14.07CNYUpdated Nov 18, 2026
Avg 10-Day Volume
9.67MSharesUpdated Nov 18, 2026
Avg 30-Day Volume
9.19MSharesUpdated Nov 18, 2026
Diluted EPS (TTM)
0.7100CNYUpdated Nov 18, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3: safe zoneNotable
Altman Z-Score: 3.00
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $680.34M, above the global median of $566.17MNotable